| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |